By The Pulseline News Desk
Sri Lanka’s medicine pricing framework is set for a fresh test as health authorities move to revise the maximum retail prices of 60 essential medicines in response to currency fluctuations and rising import costs.
The National Medicines Regulatory Authority (NMRA) has announced plans to review the controlled prices of a range of essential medicines following the recent appreciation of the US Dollar against the Sri Lankan Rupee. The move has raised concerns among patients and healthcare advocates who fear that higher medicine prices could place an additional burden on households already grappling with rising living costs.
NMRA Chairman, Specialist Dr Ananda Wijewickrama has said the review became necessary due to changes in foreign exchange rates that directly affect the cost of importing pharmaceutical products into Sri Lanka.
According to the NMRA, the existing pricing framework is governed by a gazette issued in 2023, which established maximum retail prices for 60 essential medicines. Authorities now intend to amend those regulations to reflect current market realities.
Balancing affordability and supply
The proposed revisions highlight a longstanding challenge for policymakers: balancing the affordability of medicines for consumers while ensuring that importers and suppliers can continue to maintain adequate stocks.
Sri Lanka remains heavily dependent on imported pharmaceuticals, making the sector particularly vulnerable to exchange rate movements. Even minor currency fluctuations can significantly affect procurement costs, transportation expenses, and retail pricing.
Industry stakeholders have often argued that rigid price controls can discourage imports when costs rise sharply, potentially leading to shortages of critical medicines. Consumer advocates, however, maintain that price regulations are necessary to protect vulnerable patients from excessive costs.
The NMRA’s latest review seeks to navigate this delicate balance.
Impact on patients
For many Sri Lankan families, healthcare spending represents a growing share of household expenses. Any increase in medicine prices could be particularly difficult for patients suffering from chronic illnesses such as diabetes, hypertension, cardiovascular disease, and respiratory conditions that require long-term treatment.
Public health experts note that even relatively small price increases can influence treatment adherence, especially among low-income groups who rely on regular medication.
The possibility of higher prices has therefore renewed calls for stronger social protection measures and improved access to affordable medicines through the public health system.
Crackdown on overpricing continues
While considering revisions to the official pricing structure, the NMRA has also intensified enforcement efforts against pharmacies accused of violating existing regulations.
Dr Wijewickrama has said inspections and raids are continuing across the country to identify pharmacies selling medicines above the approved maximum retail prices. Such operations are aimed at ensuring compliance with current regulations and protecting consumers from unauthorised mark-ups.
The authority has repeatedly warned pharmacy operators that legal action can be taken against those found charging prices beyond approved limits.
A sensitive policy decision
The forthcoming amendments are likely to attract close scrutiny from healthcare professionals, consumer groups, pharmaceutical importers, and patient advocacy organisations.
As Sri Lanka continues its economic recovery, medicine affordability remains a sensitive public issue. The government’s challenge will be to ensure that essential medicines remain accessible to patients while maintaining a stable supply chain capable of meeting national healthcare needs.
The final pricing decision, expected following consultations and regulatory review, will determine how that balance is struck in the months ahead.
Leave a comment